Trial Profile
A double-blind randomized placebo controlled study of atomoxetine in patients with Parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary) ; Levodopa
- Indications Parkinson's disease
- Focus Therapeutic Use
- 03 Dec 2015 New trial record